DNDi: 15 years of putting patients before profits

Some diseases affect billions, yet they attract little interest from the pharmaceutical industry and public sector because those affected are poor, leaving doctors powerless to treat patients.

When Doctors Without Borders (MSF) won the Nobel prize in 1999, they used the proceeds to explore a new, non-profit way to drive medical innovation. Together with public health research institutions from several countries and the World Health Organization, Doctors Without Borders launched DNDi in 2003.

In the last 15 years, we've searched millions of compounds, and our scientists have worked to turn these into safe drugs. We've run clinical trials in some of the most inhospitable areas of the world.

To date, we've delivered eight new treatments including the first all-oral treatment for sleeping sickness and over 20 candidate drugs.

We make drugs for patients, not profits.

Find out more about our non-profit R&D approach: LINK TO PR

#DNDi15Years #access2meds #makingmedicalhistory

NTDs,neglected,healthcare,poverty,research,R&D,medicine,dndi,drugs for neglected diseases initiative,pharmaceutical industry,pharma,drugs,sleeping sickness,chagas,leishmaniasis,hiv,children,neglected tropical diseases,